Julia is a Senior Partner of Trilogy Writing & Consulting, a company specialized in providing regulatory medical writing. Since she started her career as a regulatory medical writer in 1997, she has since been President of the European Medical Writers Association (EMWA) twice and is currently a member of the Executives Council for the American Medical Writers Association (AMWA). Julia is a known voice in the industry as an advocate for the importance of medical writing, writing and speaking frequently about the value of good medical writers during drug development. She is an experienced training of medical writers, running workshops for EMWA, AMWA, DIA, and pharmaceutical companies around the world. She is a Nick Thomson Fellow of EMWA and in 2022 she received the AMWA Harold Swanberg Distinguished Service Award for her contributions to medical communication.
Julia Forjanic Klapproth
Related Speaker
Mark’s career began in software development, where he spent more than a decade building solutions…
Ana Pataki is a patient advocate and a PhD student in the Faculty of Philosophy…
